270 related articles for article (PubMed ID: 24740004)
1. A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers.
Goonesekere NC; Wang X; Ludwig L; Guda C
PLoS One; 2014; 9(4):e93046. PubMed ID: 24740004
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.
Goonesekere NCW; Andersen W; Smith A; Wang X
J Cancer Res Clin Oncol; 2018 Feb; 144(2):309-320. PubMed ID: 29288362
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
[TBL] [Abstract][Full Text] [Related]
5. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
6. Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array).
Shimizu H; Horii A; Sunamura M; Motoi F; Egawa S; Unno M; Fukushige S
Biochem Biophys Res Commun; 2011 Jul; 411(1):162-7. PubMed ID: 21723258
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
8. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
[TBL] [Abstract][Full Text] [Related]
9. Screening and Identification of Key Biomarkers in Pancreatic Cancer: Evidence from Bioinformatic Analysis.
Zhang M; Di CY; Guo P; Meng LB; Shan MJ; Qiu Y; Guo PY; Dong KQ; Xie Q; Wang Q
J Comput Biol; 2020 Jul; 27(7):1079-1091. PubMed ID: 31638423
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
Kordshouli SO; Tahmasebi A; Moghadam A; Ramezani A; Niazi A
PLoS One; 2024; 19(2):e0289561. PubMed ID: 38324544
[TBL] [Abstract][Full Text] [Related]
11. Novel methylation biomarker panel for the early detection of pancreatic cancer.
Yi JM; Guzzetta AA; Bailey VJ; Downing SR; Van Neste L; Chiappinelli KB; Keeley BP; Stark A; Herrera A; Wolfgang C; Pappou EP; Iacobuzio-Donahue CA; Goggins MG; Herman JG; Wang TH; Baylin SB; Ahuja N
Clin Cancer Res; 2013 Dec; 19(23):6544-6555. PubMed ID: 24088737
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats.
Guo JC; Li J; Yang YC; Zhou L; Zhang TP; Zhao YP
PLoS One; 2013; 8(12):e82910. PubMed ID: 24376604
[TBL] [Abstract][Full Text] [Related]
15. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner.
Li H; Peng C; Zhu C; Nie S; Qian X; Shi Z; Shi M; Liang Y; Ding X; Zhang S; Zhang B; Li X; Xu G; Lv Y; Wang L; Friess H; Kong B; Zou X; Shen S
Clin Epigenetics; 2021 Jan; 13(1):18. PubMed ID: 33499904
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma: defining the pancreatic cancer [corrected] epigenome.
Corn PG
Cancer Biol Ther; 2008 Jul; 7(7):1157-9. PubMed ID: 18698160
[No Abstract] [Full Text] [Related]
18. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]